Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients. - Wikidata - wikimedia - TriplyDB

Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.

Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.

http://www.wikidata.org/entity/Q35814479

about

Multiple Forms of Glutamate Dehydrogenase in Animals: Structural Determinants and Physiological Implications Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer.Expression of glutamine metabolism-related proteins in thyroid cancer.The Glutamate Dehydrogenase Pathway and Its Roles in Cell and Tissue Biology in Health and Disease.TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors.Hopefully devoted to Q: targeting glutamine addiction in cancer.Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond.Glutamate Dehydrogenase, a Complex Enzyme at a Crucial Metabolic Branch Point.LncRNA TUG1 sponges miR-145 to promote cancer progression and regulate glutamine metabolism via Sirt3/GDH axis.Blood and Tissue Enzymatic Activities of GDH and LDH, Index of Glutathione, and Oxidative Stress among Breast Cancer Patients Attending Referral Hospitals of Addis Ababa, Ethiopia: Hospital-Based Comparative Cross-Sectional Study.The pleiotropic effects of the glutamate dehydrogenase (GDH) pathway in Saccharomyces cerevisiae Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses

P2860

Q28074448-4370806A-AE1A-44E1-B078-B02EFDCC1A58 Q37479629-2187DF3B-03A1-4C1B-9E7E-A581BA700B22 Q37619803-2DDBDE54-823B-4013-978A-4A6093D1B00E Q37728187-94FE0BB8-D735-4792-833B-B138E4871B0C Q37736897-55AB17D4-7860-47D1-801B-5CDDABA974C2 Q39205930-79B8FD61-3EA1-4469-B01C-11EE0B17DB55 Q39261665-370C5C44-2528-4B57-8BCD-6AB17B0841C9 Q41577295-B6E2672B-E507-4F46-9E00-24189EAF3D6B Q46291182-D66AEA6F-F1D2-4684-B04A-B1A11F2B76CC Q48110753-20C1D4D2-584C-4FBB-A796-AA1538346160 Q48523033-AC96B2E5-2C14-4834-B3A9-8B92735AD7EE Q55315637-9C897652-EB74-440F-B68E-674156412A66 Q58567988-060B1318-43B8-4F44-9902-8DB8CDE9942E Q58690861-5061E59A-0533-43A2-8962-AB853027197D

P2860

Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.

http://www.wikidata.org/entity/Q35814479

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Glutamate dehydrogenase is a n ...... in colorectal cancer patients.

@ast

Glutamate dehydrogenase is a n ...... in colorectal cancer patients.

@en

type

label

Glutamate dehydrogenase is a n ...... in colorectal cancer patients.

@ast

Glutamate dehydrogenase is a n ...... in colorectal cancer patients.

@en

prefLabel

Glutamate dehydrogenase is a n ...... in colorectal cancer patients.

@ast

Glutamate dehydrogenase is a n ...... in colorectal cancer patients.

@en

P1433

Q35814479-3F7C9188-6A21-457D-93D9-23C639A2C44B

P1476

Q35814479-6E2240A0-9B34-442C-8211-480DDF292FC0

P2093

Q35814479-01A2624B-6136-44E6-A77E-A35F99A76597

Q35814479-0D5B9712-DD61-42C8-8ED4-D57BF6BFE96D

Q35814479-184EC8FF-12EE-44A6-B971-6FF10172927B

Q35814479-28663211-D8A6-4CA1-AEAB-311783B63B6D

Q35814479-2E7DA1C5-3849-412C-8637-5A1100CC9F60

Q35814479-439544FC-4666-4112-88AA-5D72B656C8E9

Q35814479-52CCF9E5-BECF-4ADE-9DD2-2E06A60D7771

Q35814479-547B20E1-5C8E-44EE-9DEC-84D8444A1A97

Q35814479-66B8D0F5-15C1-47E2-9F2C-25F91BB7E5FF

Q35814479-75E34107-C685-41CC-BC27-24F265EE66C8

P2860

Q35814479-0523EC43-078B-4394-9EC3-19CBF01777F7

Q35814479-0B1BC4AF-E31A-43A2-A471-AC88E7CF0F42

Q35814479-1236E3DB-FA2A-40C1-AF0A-A0AD2853A181

Q35814479-16F2108A-02B8-43AB-A88E-C783E0D7384B

Q35814479-1D115A4D-6981-443F-8965-DD73E7D71F37

Q35814479-23FBE751-152D-404D-9C25-8B481A2E49F2

Q35814479-24814C34-E4E9-43F5-B5F8-AC4D22AF22F5

Q35814479-3189B965-9E17-410C-9958-729562C0F194

Q35814479-32000128-AC77-4E56-9194-43710DBFEC4C

Q35814479-328D8DF3-205E-431A-985E-A56ACF77F41D

P2888

Q35814479-7D1C8AB5-3DB5-4F90-A177-6D86F17A94F4

P304

Q35814479-C46445EB-CA92-486C-AC99-6EC1F5594FCF

P31

Q35814479-8DBD6BB2-A1A3-4082-9623-BBC68345969E

P356

Q35814479-7F0448B2-7D24-4E0F-9617-B0480772F37D

P478

Q35814479-C93FA7A8-7D7B-473A-A9F4-8F19F0EE7ABA

P577

Q35814479-3B260443-F179-405F-949D-FCED91E639EA

P5875

Q35814479-E248BFCC-84C8-4B29-B678-94F5315567D7

P6179

Q35814479-A9CFA21B-C82B-4879-AB4E-6E4FE633DEE4

P698

Q35814479-12BFFCB2-2736-4821-A475-1015848A6688

P921

Q35814479-2C6EAA1C-42F9-4C11-A774-099A3DF8E2D5

P932

Q35814479-BA9D13DC-704F-48AB-82F0-8BE4572C9E6A

P356

S12967-015-0500-6

P1433

Journal of Translational Medicine

P1476

Glutamate dehydrogenase is a n ...... in colorectal cancer patients.

@en

P2093

Bin Yang

http://www.w3.org/2001/XMLSchema#string

Bing Zeng

http://www.w3.org/2001/XMLSchema#string

Canfeng Cai

http://www.w3.org/2001/XMLSchema#string

Chaoming Tang

http://www.w3.org/2001/XMLSchema#string

Fanghai Han

http://www.w3.org/2001/XMLSchema#string

Gaojie Liu

http://www.w3.org/2001/XMLSchema#string

Huilin Ye

http://www.w3.org/2001/XMLSchema#string

Jie Zhu

http://www.w3.org/2001/XMLSchema#string

Liangtao Ye

http://www.w3.org/2001/XMLSchema#string

Menglei Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function

The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4

SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer

Cancer treatment and survivorship statistics, 2014

Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.

Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells.

PGC-1α supports glutamine metabolism in breast cancer.

The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation

P2888

s12967-015-0500-6

P304

144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-015-0500-6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276070347

http://www.w3.org/2001/XMLSchema#string

P6179

1001343456

http://www.w3.org/2001/XMLSchema#string

P698

25947346

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4490642

http://www.w3.org/2001/XMLSchema#string